AIGH Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $913K | Hold |
539,300
| – | – | 0.41% | 27 |
|
|
2025
Q1 | $1.1M | Hold |
539,300
| – | – | 0.46% | 32 |
|
|
2024
Q4 | $1.77M | Hold |
539,300
| – | – | 0.55% | 26 |
|
|
2024
Q3 | $1.48M | Hold |
539,300
| – | – | 0.42% | 28 |
|
|
2024
Q2 | $2.19M | Hold |
539,300
| – | – | 0.68% | 22 |
|
|
2024
Q1 | $3.5M | Buy |
539,300
+190,000
| +54% | +$1.23M | 1.05% | 25 |
|
|
2023
Q4 | $1.64M | Hold |
349,300
| – | – | 0.65% | 32 |
|
|
2023
Q3 | $1.46M | Hold |
349,300
| – | – | 0.69% | 35 |
|
|
2023
Q2 | $1.1M | Buy |
349,300
+4,300
| +1% | +$13.5K | 0.45% | 39 |
|
|
2023
Q1 | $1.53M | Buy |
+345,000
| New | +$1.53M | 0.56% | 37 |
|